Log in  First Connection?


Incidence of hyperkalemia in anuric hemodialysis patients treated with sacubitril/valsartan
 3 min.

 Published on 10/04/2024 |  Original article (Full-text)  | Xiaofan Li et al. | Hemodialysis International 2024; AOP: 10.1111/hdi.13150

Sacubitril/valsartan is a crystal complex that combines the neprilysin inhibitor sacubitril with the angiotensin receptor blocker valsartan. Neprilysin, a neutral endopeptidase, breaks down numerous endogenous vasoactive peptides, including natriuretic peptides, bradykinin, and adrenomedullin. Natriuretic...

Prevention of dialysis disequilibrium syndrome in children with advanced uremia with a structured hemodialysis protocol: A quality improvement initiative study
 5 min.

 Published on 03/04/2024 |  Original article (Full-text)  | Sidharth Kumar Sethi et al. | Hemodialysis International 2024; 28(2): 216-24

Dialysis disequilibrium syndrome (DDS), first described in 1962, is a rare spectrum of neurological symptoms common among high‐risk populations such as extremes of age or patients with advanced azotemia, at the time of dialysis initiation or if resumed after an interval. Most cases are mild and...

Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial
 4 min.

 Published on 27/03/2024 |  Original article (Full-text)  | Masanori Kato et al. | Therapeutic Apheresis 2024; AOP: 10.1111/1744-9987.14123

Individuals undergoing dialysis have a high incidence of cardiovascular disease (CVD), and the mortality rate is also much higher than that of individuals not undergoing dialysis [1, 2]. Despite advances in various drug therapies and interventional techniques, CVD remains the leading cause of death in...

Transjugular approach in aspiration thrombectomy and angioplasty of a thrombosed straight arteriovenous graft compared to the direct hemodialysis access approach
 4 min.

 Published on 20/03/2024 |  Original article (Full-text)  | JungWon Kwak et al. | Hemodialysis International 2024; 28(2): 162-9

Thrombosis of dialysis access accounts for 65%–85% of access loss and is a significant source of health care expenditure in patients with end‐stage renal disease. Although monitoring and surveillance of access points for hemodialysis are performed to identify grafts that are at risk of clotting,...